Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $28.4913 per ML under NDC 00548570100. Its NADAC has been published 444 times since Feb 21, 2018.
FDA first approved this application on Nov 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548570100
Classification
Generic
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077334FDA Approved
11/28/2017
TE Code
AB
On Market Since
11/28/2017
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 444 times since Feb 21, 2018, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.4913 per ML |
|---|---|
| All-time high | $82.4805 (Apr 11, 2018) |
| All-time low | $25.6030 (May 20, 2026) |
| 52-week high | $33.1451 |
| 52-week low | $25.6030 |
| Median price | $43.7877 |
| Average price | $46.3057 |
| Largest weekly change | +39.7% (Aug 21, 2024) |
| Weeks tracked | 444 |
| Tracking since | Feb 21, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amphastar Pharmaceuticals, Inc., is $28.4913 per ML (NDC 00548570100), effective Aug 19, 2026.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 65.3%. It has been tracked across 444 weekly CMS publications since Feb 21, 2018.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Feb 21, 2018, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $25.6030 (May 20, 2026) to a high of $82.4805 (Apr 11, 2018), with a median of $43.7877 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.3134 per ML — about 36% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 00548570100) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.